Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico-Reference-Cited by-同舟云学术

Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico

Published:2010-12 Issue:8 Volume:13 Page:903-914
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Contreras-Hernandez Iris,Becker Debbie,Chancellor Jeremy,Kühne Felicitas,Mould-Quevedo Joaquin,Vega Gabriela,Marfatia Shalaka

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference44 articles.

1. Bravo-Garcia E, Magis-Rodriquez C, Saavedra J. New estimates in Mexico: more than 180 000 people living with HIV. Abstract CDC0411. XVI International AIDS Conference; 2006 August 13–18; Toronto, ON, Canada.

2. Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico;Bautista-Arredondo;AIDS,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. US cost-utility model of lenacapavir plus optimized background regimen (OBR) vs fostemsavir plus OBR and ibalizumab plus OBR for people with HIV with multidrug resistance;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Subdividing ART patients and analyzing the medical burden by modeling of CD4 cell count;Journal of Family Medicine and Primary Care;2023

3. Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries;Bulletin of the World Health Organization;2014-04-01

4. Cost-Effectiveness of Newer Antiretroviral Drugs in Treatment-Experienced Patients With Multidrug-Resistant HIV Disease;JAIDS Journal of Acquired Immune Deficiency Syndromes;2013-12-01

5. A Methodological Review of Models Used to Estimate the Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV Infection;PharmacoEconomics;2013-11